Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bladder preservation with panitumumab and radiotherapy
NL-OMON28908Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Jan 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of panitumumab in bladder cancer, sponsored by Netherlands Cancer Institute. Started Jan 2011; status: recruiting.
02
Drugs
panitumumab
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NL-OMON28908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28908.